XML 55 R40.htm IDEA: XBRL DOCUMENT v3.3.1.900
Summary of Significant Accounting Policies (Details) - USD ($)
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Summary of Significant Accounting Policies [Abstract]      
Net trade receivable $ 754,000 $ 549,000  
Grants receivable 324,000 493,000  
Allowance for doubtful accounts $ 101,000    
Ownership percentage 20.00%    
Foreign currency translation and other comprehensive loss, foreign currency transaction gains and losses [Abstract]      
Foreign currency gain (loss) included in comprehensive loss $ (423,000) 122,900  
Change in foreign currency translation and other comprehensive income/(loss) from equity investments (424,000) 125,000 $ 119,000
Foreign currency transaction gain (loss) other than functional currency $ 5,000 $ (338,000)  
Finite-Lived Intangible Assets [Line Items]      
Intangible asset, useful life 10 years    
Equipment [Member] | Minimum [Member]      
Property, Plant and Equipment [Line Items]      
Equipment useful life 36 months    
Equipment [Member] | Maximum [Member]      
Property, Plant and Equipment [Line Items]      
Equipment useful life 120 months    
LifeMap Sciences, Ltd. [Member]      
Available for sale securities in foreign investments [Abstract]      
Common stock of HDST shares acquired 9,180,000    
Common stock value of HDST shares acquired $ 850,000    
Value of available for sale securities 753,000    
Unrealized loss included in other comprehensive loss $ 100,000    
Licensed Technology [Member]      
Finite-Lived Intangible Assets [Line Items]      
Intangible asset, useful life 10 years    
Treasury Shares [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Anti-dilutive shares excluded from computation of diluted loss per share (in shares) 4,472,586 4,893,942 10,697,715
Stock Options [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Anti-dilutive shares excluded from computation of diluted loss per share (in shares) 5,194,313 3,974,326 4,567,135
Warrants [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Anti-dilutive shares excluded from computation of diluted loss per share (in shares) 9,190,782 9,194,679 9,751,615